Targeting Leukemia-Specific Dependence on the De Novo Purine Synthesis Pathway

Treatment of human acute myeloid leukemia (AML) cells with a PAICS inhibitor suppressed their proliferation by inhibiting DNA synthesis and promoting apoptosis and had anti-leukemic effects in AML PDX models.